MEN1 Syndrome and Parathyroid Disease
Written by John P. Sabra, MD FACS
Updated September 2026
Educational only. This article is not medical advice. Always consult your physician about your individual situation.
Multiple Endocrine Neoplasia type 1 (MEN1) is an inherited genetic syndrome that causes tumors in three endocrine systems: parathyroid, pituitary, and pancreas. Hyperparathyroidism is almost universal in MEN1 patients, it appears earlier than in sporadic cases, and it is fundamentally different from classic primary hyperparathyroidism in ways that change surgical management. Understanding the syndrome changes both the workup and the operative plan.
MEN1 is caused by a mutation in the MEN1 gene, and it is inherited in an autosomal dominant pattern, meaning a parent with MEN1 has a 50% chance of passing it to each child. The syndrome drives overgrowth of tissue in specific endocrine glands. Parathyroid disease occurs in essentially all MEN1 patients, often by age 40. Pituitary tumors occur in 30 to 40% of patients, while pancreatic endocrine tumors occur in 30 to 80% of patients.
The parathyroid disease in MEN1 differs from sporadic primary hyperparathyroidism in two important ways. First, it is almost always multi-gland disease rather than a single adenoma. Second, it tends to recur over time even after a well-performed operation, because the genetic mutation keeps driving abnormal growth in any remaining parathyroid tissue.
When to Suspect MEN1
-
Young age at presentation with primary hyperparathyroidism: Particularly under age 40.
-
Family history of hyperparathyroidism, pituitary tumors, or pancreatic tumors: This points toward the inherited syndrome.
-
Multi-gland parathyroid disease: All four glands abnormal at the first surgery.
-
Recurrent hyperparathyroidism after previous successful surgery: Particularly when multiple glands are later found to be abnormal.
-
History of pituitary or pancreatic tumors: This always prompts MEN1 evaluation.
⚕ Clinical note
Genetic testing for MEN1 should be offered to any patient with primary hyperparathyroidism who is under 40, has multi-gland disease, has recurrent disease, or has a personal or family history suggestive of the syndrome. A positive test carries implications for both the patient and first-degree relatives, who may carry the same mutation.
Surgical Approach in MEN1
The surgical approach for MEN1 hyperparathyroidism is fundamentally different from sporadic disease. Because all four parathyroid glands typically harbor abnormal tissue, even if not all are visibly enlarged, focused single-gland surgery is generally not appropriate. The standard operations are:
-
Subtotal parathyroidectomy (3.5 glands): Three glands are removed completely, and a small portion of one gland (typically about 50 mg) is left behind to maintain some calcium regulation. This is the most common approach.
-
Total parathyroidectomy with autotransplantation: All four glands are removed, and a portion of one gland is transplanted into a forearm muscle. This makes reoperation easier if the disease recurs.
| Approach | Trade-Offs |
|---|---|
| Subtotal parathyroidectomy | Preserves calcium balance, simpler surgery, more difficult reoperation if recurrence occurs in the neck. |
| Total with autotransplant | Easier future reoperation if recurrence occurs in the transplant, higher risk of permanent hypoparathyroidism if the transplant fails. |
The choice between these approaches depends on patient factors, surgeon experience and preference, and the specific anatomy found at surgery. Both are reasonable. Cervical thymectomy (removal of the upper thymus, which often contains extra parathyroid tissue) is typically performed at the same time.
Recurrence in MEN1
Recurrence is common in MEN1 over time. The remaining parathyroid tissue is genetically predisposed to abnormal growth. Recurrence rates of 30 to 50% at 10 to 15 years are reported. This is not a sign of inadequate surgery; it reflects the underlying biology of the syndrome.
Reoperation for recurrent MEN1 hyperparathyroidism is essentially universal over a lifetime for these patients. The surgical strategy and the timing of the first operation should account for the likelihood of future operations. That is one of the reasons MEN1 patients should be managed at centers experienced with the syndrome.
Surveillance for the Other MEN1 Tumors
MEN1 patients need lifelong surveillance for pituitary and pancreatic tumors in addition to parathyroid disease. Annual labs typically include pituitary hormones, gastrin, glucose, insulin, and pancreatic polypeptide. Imaging (pituitary MRI, abdominal MRI or CT) is performed at regular intervals based on your clinical status.
⚕ Clinical note
A diagnosis of MEN1 in a patient with primary hyperparathyroidism is a family event. First-degree relatives should be offered genetic counseling and testing. Children who test positive often begin screening for endocrine tumors in adolescence. Early identification allows surveillance before tumors cause clinical disease.
The Bottom Line
MEN1 is an inherited syndrome that causes multi-gland parathyroid disease, often at a young age and with high recurrence rates over time. The surgical approach differs from sporadic disease (subtotal or total parathyroidectomy with autotransplantation, plus cervical thymectomy). Recurrence is the rule rather than the exception. Lifelong surveillance for parathyroid, pituitary, and pancreatic tumors is essential. Treatment is best at centers experienced with MEN syndromes.
If you have been diagnosed with MEN1, seek a multidisciplinary endocrine team experienced specifically with the syndrome, and make sure your first-degree relatives are offered genetic counseling.
This article is intended for patient education only. It does not constitute medical advice and does not replace a consultation with your physician. Individual patient circumstances and clinical judgment determine the appropriate evaluation and management for every patient.
More from the Parathyroid Disease series
Ready to Talk to a Specialist?
A thyroid specialist can review your specific results, answer your questions, and help you understand exactly what your next steps should be. The ATLAS network connects you with experienced thyroid and parathyroid expert physicians who focus on thyroid disease.
Find a Thyroid Specialist Near You →